Desensibilização em transplant Desensibilização em transplant renal – experiência da PUCRS renal – experiência da PUCRS (relato de caso) (relato de caso) HOSPITAL SÃO LUCAS DA PUCRS SERVIÇO DE NEFROLOGIA 2012 David Saitovitch
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Desensibilização em transplante Desensibilização em transplante renal – experiência da PUCRSrenal – experiência da PUCRS
(relato de caso)(relato de caso)
HOSPITAL SÃO LUCAS DA PUCRS
SERVIÇO DE NEFROLOGIA
2012
David Saitovitch
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
IgA Nephropathy
G.C.V.J., 49-year-old, Brazilian, caucasian, female
Case presentation
IgA Nephropathy
dialysis since 07/2000
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
IgA Nephropathy
2 pregnancies, 10 blood transfusions, 1st kidney tx 06/2003
dialysis since 07/2000
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
IgA Nephropathy
Primary non-function....
2 pregnancies, 10 blood transfusions, 1st kidney tx 06/2003
dialysis since 07/2000
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
IgA Nephropathy
Primary non-function.... Etiology????
2 pregnancies, 10 blood transfusions, 1st kidney tx 06/2003
dialysis since 07/2000
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
HemodialysisWaiting list
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
HemodialysisWaiting list
CMs
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
HemodialysisWaiting list
CMs → +
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
HemodialysisWaiting list
CMs → +
PRA (CDC) → >90%
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
HemodialysisWaiting list
vascular access...
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
HemodialysisWaiting list
vascular access...dificult!
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Peritoneal dialysis 03/2006
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Peritoneal dialysis 03/2006
Peritonitis
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
ultrafiltration...failure!
Peritoneal dialysis 03/2006
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis 03/2008
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
vascular access...dificult!
Hemodialysis 03/2008
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
vascular access...dificult!
Priority on the waiting list (2009)!
Hemodialysis 03/2008
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
Priority on the waiting list!
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
Priority on the waiting list!
↑CMs
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
Priority on the waiting list!
↑CMs → +
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
Priority on the waiting list!
↑CMs → +
2009
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
Priority on the waiting list!
PRA (CDC) → >95%
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
Priority on the waiting list!
PRA (Flow) → >95%
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
Priority on the waiting list!
Desensitization protocol
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
Priority on the waiting list!
Desensitization protocol
ivig
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
Priority on the waiting list!
Desensitization protocol
ivig2g/Kg (monthly)
2010
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
Priority on the waiting list!
Desensitization protocol
ivig2g/Kg (monthly)
2010
CMs → +
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
Priority on the waiting list!
Desensitization protocol
ivig2g/Kg (monthly)
2010
CMs → +
PRA...??
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
Priority on the waiting list!
Desensitization protocol
PP/ivig0.1g/Kg
Jan 2011
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Hemodialysis
Priority on the waiting list!
Desensitization protocol
PP/ivig0.1g/Kg
Jan 2011
Deceased donor
allograft 21/02/11
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Deceased donor
allograft 21/Feb/11
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Deceased donor
allograft 21/Feb/11
AA BB DRDR
RecipientRecipient 2,242,24 35,6535,65 13,1613,16
DonorDonor 2, -2, - 51,5751,57 13,1713,17
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Deceased donor
allograft 21/Feb/11
AA BB DRDR
RecipientRecipient 2,242,24 35,6535,65 13,1613,16
DonorDonor 2, -2, - 51,5751,57 13,1713,17
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Deceased donor
allograft 21/Feb/11
AA BB DRDR
RecipientRecipient 2,242,24 35,6535,65 13,1613,16
DonorDonor 2, -2, - 51,5751,57 13,1713,17
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Deceased donor
allograft 21/Feb/11
AA BB DRDR
RecipientRecipient 2,242,24 35,6535,65 13,1613,16
DonorDonor 2, -2, - 51,5751,57 13,1713,17
DQ2
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Deceased donor
allograft 21/Feb/11
CDC Cross-match (-)
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Deceased donor
allograft 21/Feb/11
CDC Cross-match (-)
Flow Cross-match (+)
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Deceased donor
allograft 21/Feb/11
CDC Cross-match (-)
Flow Cross-match (+)
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Deceased donor
allograft 21/Feb/11
Cold ischemia – 32 h
Anastomosis time – 40 min.
G.C.V.J., 49-year-old Brazilian, Caucasian female
Case presentation
Deceased donor
allograft 21/Feb/11
ImmunosuppressionThymo (1,5mg/kg) Tac MMF Prednisone PP/ivig
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD
(Tac + MMF + Pred)
PP/IVIG3x/week
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
B*5714/02/11MFI=5034 28/02/11
MFI=2465
11/03/11MFI=8694
14/02/11MFI=2434
28/02/11MFI=2549
11/03/11MFI=12093DQ*2
B*5714/02/11MFI=5034 28/02/11
MFI=2465
11/03/11MFI=8694
14/02/11MFI=2434
28/02/11MFI=2549
11/03/11MFI=12093DQ*2
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
B*5714/02/11MFI=5034 28/02/11
MFI=2465
11/03/11MFI=8694
14/02/11MFI=2434
28/02/11MFI=2549
11/03/11MFI=12093DQ*2
B*5714/02/11MFI=5034 28/02/11
MFI=2465
11/03/11MFI=8694
14/02/11MFI=2434
28/02/11MFI=2549
11/03/11MFI=12093DQ*2
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
graft biopsy
C4d+
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
Tac dose (blood levels 13 ng/ml)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
bortezomib 1st
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
Tac dose (blood levels 16.3 ng/ml)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
bortezomib 2nd
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
bortezomib 3rd
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
bortezomib 4th
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
B*5714/02/11MFI=5034
28/02/11MFI=2465
11/03/11MFI=8694
DQ*2
14/02/11MFI=2434
28/02/11MFI=2549
11/03/11MFI=12093
21/03/11MFI=5998
21/03/11MFI=4218
B*5714/02/11MFI=5034
28/02/11MFI=2465
11/03/11MFI=8694
DQ*2
14/02/11MFI=2434
28/02/11MFI=2549
11/03/11MFI=12093
21/03/11MFI=5998
21/03/11MFI=4218
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
0 1 2 3 4 5 6 7 8 9 10111213141516171819202122232425262728
sCr
(mg/dL)
(days)
Thymoglobuline
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female
HD HD
PP/IVIG3x/week
PP/IVIG3x/week
(Tac + MMF + Pred)
DISCHARGED
DISCHARGED
0
1
2
3
4
5
6
7
8
9
10
1 2 3 4 5 6 7 8 9 10 11 12
sCr
(mg/dL)
(mo)
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female(Tac + MMF + Pred)
B*57 DQ*2
14/02/11MFI=5034
28/02/11MFI=2465
11/03/11MFI=8694
21/03/11MFI=5998 31/03/11
MFI=553214/02/11MFI=2434
28/02/11MFI=2549
11/03/11MFI=12093
21/03/11MFI=4218
31/03/11MFI=2188
20/04/11MFI=4640
20/04/11MFI=2141
0
1
2
3
4
5
6
7
8
9
10
1 2 3 4 5 6 7 8 9 10 11 12
sCr
(mg/dL)
(mo)
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female(Tac + MMF + Pred)
14/02/11MFI=5034
28/02/11MFI=2465
11/03/11MFI=8694
21/03/11MFI=5998
31/03/11MFI=5532
20/04/11MFI=4640
05/05/11MFI=3435
14/02/11MFI=2434
28/02/11MFI=2549
11/03/11MFI=12093
21/03/11MFI=4218
31/03/11MFI=2188
20/04/11MFI=2141
05/05/11MFI=1322
23/05/11MFI=3013
23/05/11MFI=6038
B*57 DQ*2
14/02/11MFI=5034
28/02/11MFI=2465
11/03/11MFI=8694
21/03/11MFI=5998
31/03/11MFI=5532
20/04/11MFI=4640
05/05/11MFI=3435
14/02/11MFI=2434
28/02/11MFI=2549
11/03/11MFI=12093
21/03/11MFI=4218
31/03/11MFI=2188
20/04/11MFI=2141
05/05/11MFI=1322
23/05/11MFI=3013
23/05/11MFI=6038
B*57 DQ*2
0
1
2
3
4
5
6
7
8
9
10
1 2 3 4 5 6 7 8 9 10 11 12
sCr
(mg/dL)
(mo)
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
1 2 3 4 5 6 7 8 9 10 11 12
sCr
(mg/dL)
(mo)
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female(Tac + MMF + Pred)
APN
0
1
2
3
4
5
6
7
8
9
10
1 2 3 4 5 6 7 8 9 10 11 12
sCr
(mg/dL)
(mo)
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female(Tac + MMF + Pred)
APN - Cefepime
14/02/11MFI=5034
28/02/11MFI=2465
11/03/11MFI=8694
21/03/11MFI=5998
31/03/11MFI=5532
20/04/11MFI=4640
05/05/11MFI=3435
23/05/11MFI=6038
04/08/11MFI=2045
14/02/11MFI=2434
28/02/11MFI=2549
11/03/11MFI=12093
21/03/11MFI=4218
31/03/11MFI=2188
20/04/11MFI=2141
05/05/11MFI=1322
23/05/11MFI=3013
04/08/11MFI=1457
DQ*2B*57
0
1
2
3
4
5
6
7
8
9
10
1 2 3 4 5 6 7 8 9 10 11 12
sCr
(mg/dL)
(mo)
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
1 2 3 4 5 6 7 8 9 10 11 12
sCr
(mg/dL)
(mo)
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female(Tac + MMF + Pred)
0
1
2
3
4
5
6
7
8
9
10
1 2 3 4 5 6 7 8 9 10 11 12
sCr
(mg/dL)
(mo)
Case presentation
G.C.V.J., 49-year-old Brazilian, Caucasian female(Tac + MMF + Pred)
Acknowledgements to Acknowledgements to Dr. Jorge M. Neumann et al.Laboratorio de Imunologia de Transplantes – Hospital Don Vicente Scherer
Related Documents
